Explained herein are pharmaceutical packaging programs which reduce oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-sensitive medicines, this kind of methods such as a syringe with an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with very small permeability to oxygen and com